Skip to content

GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer

Brief Intervention to Reduce Anxiety and Promote Resilience in Caregivers of Youth With Cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05415007
Enrollment
40
Registered
2022-06-10
Start date
2022-09-21
Completion date
2027-06-30
Last updated
2026-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Any types of cancer

Brief summary

The purpose of this study is to examine a psychotherapeutic and psycho-educational intervention offered in virtual settings to caregivers of youth with cancer. Human subjects must be used because they are the object of the intervention.

Detailed description

PRIMARY OBJECTIVE(S)- To examine the feasibility and accessibility of a brief intervention for caregivers of youth with newly-diagnosed cancer as a preliminary, data-generating step toward applying for a larger NCI R34 grant evaluating the efficacy of the program in a randomized controlled trial. SECONDARY OBJECTIVE(S)- We hope to learn whether a psycho-educational, psychotherapeutic intervention offered in a virtual setting to caregivers of children diagnosed with cancer is feasible, is acceptable, and can prevent, minimize, or improve symptoms of psychological distress (including symptoms of anxiety, depression, and post-traumatic stress disorder). We also hope to further our understanding of family stress and expand the idea for a need of mental health services in pediatric oncology. We aim to further understand intervention strategies for domains of family stress, reducing levels of caregiver anxiety, and promoting resilience for caregivers. This is important because these symptoms can affect the quality of life of caregivers and affect their ability to adhere to their children's treatments.

Interventions

BEHAVIORALGOLD Program

Participant will receive a 2-hour interventional session

BEHAVIORALTreatment as usual (TAU)

Participant will receive treatment-As-Usual which consist of information about diagnosis routinely-disseminated by personnel and providers.

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

Inclusion and

Exclusion criteria

Parents Inclusion * Child (0-17yrs) with recent (\<12 mo) cancer diagnosis * Fluent in English * Consent to research Exclusion: * Lack of proficiency in written and spoken English * Parent is under age 18 * Active Suicidal Ideation * Child with cancer does not provide assent Inclusion and

Design outcomes

Primary

MeasureTime frameDescription
Number of caregivers who enroll in the GOLD program1 monthMeasurement will be based on the percentage of caregivers who provide consent, and are retained in the program through 1-month follow-up.

Secondary

MeasureTime frameDescription
Acceptability of the GOLD Program for caregivers1 monthAcceptability will be measure by the percentage of caregivers who provide complete data, and who are retained through 1-month follow-up

Countries

United States

Contacts

CONTACTVictoria E. Cosgrove, PhD
veileen@stanford.edu650-995-6848
PRINCIPAL_INVESTIGATORVictoria E. Cosgrove, PhD

Stanford University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 28, 2026